Paladin Advisory Group, LLC - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 40 filers reported holding LUMOS PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Paladin Advisory Group, LLC ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$14,4770.0%4,3870.0%0.01%0.0%
Q2 2023$14,477
-0.3%
4,3870.0%0.01%0.0%
Q1 2023$14,521
-8.3%
4,3870.0%0.01%
-14.3%
Q4 2022$15,837
-58.3%
4,387
+0.1%
0.01%
-60.0%
Q3 2022$38,000
+15.2%
4,3820.0%0.04%
+25.0%
Q2 2022$33,000
-17.5%
4,3820.0%0.03%
-15.2%
Q1 2022$40,000
+33.3%
4,3820.0%0.03%
+37.5%
Q4 2021$30,0004,3820.02%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$6,714,0001.63%
Investors Financial Group, LLC 115,260$1,901,0001.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,169$15,437,0000.45%
NEA Management Company, LLC 526,663$8,685,0000.35%
Logos Global Management LP 50,000$825,0000.16%
Wealth Advisors of Iowa, LLC 11,760$194,0000.15%
Blackstone Inc. 468,145$7,720,0000.03%
Jefferies Group LLC 120,651$1,990,0000.02%
Texas Yale Capital Corp. 15,000$247,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 12,043$199,0000.00%
View complete list of LUMOS PHARMA INC shareholders